Phase I clinical and pharmacokinetic study of trabectedin and carboplatin in patients with advanced solid tumors

By Vidal Laura  

Investigational New Drugs, Vol. 30, Iss. 2, 2012-04 ,pp. : 616-628

Springer Publishing Company

Access to resources Recommend Favorite

A phase I and pharmacokinetic study of irofulven and cisplatin administered in a 30-min infusion every two weeks to patients with advanced solid tumors

By Hilgers Werner   Faivre Sandrine   Chieze Stéphanie   Alexandre Jérôme   Lokiec François   Goldwasser François   Raymond Eric   Kahatt Carmen   Taamma Abdelkrim   Weems Garry   MacDonald John   Misset Jean-Louis   Cvitkovic Esteban  

Investigational New Drugs, Vol. 24, Iss. 4, 2006-07 ,pp. : 311-319

Springer Publishing Company

Access to resources Recommend Favorite

Phase I trial of three-weekly Docetaxel, Carboplatin and oral lenalidomide (Revlimid®) in patients with advanced solid tumors

By Kalmadi S.   Davis M.   Dowlati A.   O’Keefe S.   Cline-Burkhardt M.   Pelley R.   Borden E.   Dreicer R.   Bukowski R.   Mekhail T.  

Investigational New Drugs, Vol. 25, Iss. 3, 2007-06 ,pp. : 211-216

Springer Publishing Company

Access to resources Recommend Favorite

Phase I dose escalation clinical trial of phenylbutyrate sodium administered twice daily to patients with advanced solid tumors

By Camacho Luis   Olson Jon   Tong William   Young Charles   Spriggs David   Malkin Mark  

Investigational New Drugs, Vol. 25, Iss. 2, 2007-04 ,pp. : 131-138

Springer Publishing Company

Access to resources Recommend Favorite

A phase I clinical and pharmacokinetic study of CS-682 administered orally in advanced malignant solid tumors

By Delaunoit Thierry   Burch Patrick   Reid Joel   Camoriano John   Kobayash Tomowo   Braich Theodore   Kaur Judith   Rubin Joseph   Erlichman Charles  

Investigational New Drugs, Vol. 24, Iss. 4, 2006-07 ,pp. : 327-333

Springer Publishing Company

Access to resources Recommend Favorite